Abstract CT301: A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors-Reference-Cited by-同舟云学术

Abstract CT301: A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors

Published:2020-08-13 Issue: Volume: Page:
ISSN:
Container-title:Bioinformatics, Convergence Science, and Systems Biology
language:
Short-container-title:

Author:

Lopez Juanita S.,Camidge Ross,Iafolla Marco,Rottey Sylvie,Schuler Martin,Hellmann Matthew,Balmanoukian Ani,Dirix Luc,Gordon Michael,Sullivan Ryan,Henick Brian S.,Drake Charles,Wong Kit,LoRusso Patricia,Ott Patrick,Fong Lawrence,Schiza Aglaia,Yachnin Jeffery,Ottensmeier Christian,Braiteh Fadi,Bendell Johanna,Leidner Rom,Fisher George,Jerusalem Guy,Molenaar-Kuijsten Laura,Schmidt Marcus,Laurie Scott A.,Aljumaily Raid,Rittmeyer Achim,Gort Eelke,Melero Ignacio,Mueller Lars,Sabado Rachel,Twomey Patrick,Huang Jack,Yadav Manesh,Zhang Jingbin,Mueller Felicitas,Derhovanessian Evelyna,Sahin Ugur,Türeci Özlem,Powles Thomas

Publisher

American Association for Cancer Research

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The current therapeutic cancer vaccines landscape in non‐small cell lung cancer;International Journal of Cancer;2024-08-07

2. mRNA vaccines in the treatment of cancer;Oncology in Clinical Practice;2024-08-06

3. Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells;Molecular Oncology;2024-05-22

4. Cancer mRNA vaccines: clinical advances and future opportunities;Nature Reviews Clinical Oncology;2024-05-17

5. Nucleic acid-based drugs for patients with solid tumours;Nature Reviews Clinical Oncology;2024-04-08